.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
US Department of Justice
McKesson
Cerilliant
Cantor Fitzgerald
Covington
Federal Trade Commission
Chubb
Healthtrust
Dow

Generated: December 16, 2017

DrugPatentWatch Database Preview

ACTIFED Drug Profile

« Back to Dashboard

Which patents cover Actifed, and what generic alternatives are available?

Actifed is a drug marketed by Glaxosmithkline and is included in two NDAs.

The generic ingredient in ACTIFED is codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride. There are nineteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.

Summary for ACTIFED

Drug patent expirations by year for ACTIFED

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
GlaxosmithklineACTIFEDpseudoephedrine hydrochloride; triprolidine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL018996-001Jun 17, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
GlaxosmithklineACTIFED W/ CODEINEcodeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochlorideSYRUP;ORAL012575-003Apr 4, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Cerilliant
Accenture
QuintilesIMS
Novartis
Farmers Insurance
McKesson
Colorcon
Julphar
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot